Abeona Therapeutics (ABEO) Cash & Equivalents (2010 - 2026)
Abeona Therapeutics (ABEO) posted Cash & Equivalents of $56.23 million for Q2 2026, down 65.6% from $163.54 million a year earlier and down 8.4% from the prior quarter.
Powered by 
Analysis
Abeona Therapeutics (ABEO) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025, Abeona Therapeutics' Cash & Equivalents came in at $78.44 million, up 231.0% from FY2024.
- Annual Cash & Equivalents has increased for three consecutive years, with a five-year compound annual growth rate of 42.0% (FY2020 to FY2025).
- In prior years, Abeona Therapeutics' Cash & Equivalents was $23.7 million in FY2024 (+60.0%), $14.81 million in FY2023 (+1.8%), $14.56 million in FY2022 (-62.5%) and $38.83 million in FY2021 (+186.1%).
- The Q2 2026 figure stands as the lowest quarterly Cash & Equivalents since Q1 2025.
- On a year-over-year basis, Cash & Equivalents increased in six of the last eight quarters, with growth averaging 188.3%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q3 2021, with growth of 431.3%; the weakest was Q1 2023, with a decline of 80.9%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $61.37 million (Q1 2026), $78.44 million (Q4 2025) and $83.22 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Abeona Therapeutics | 286.70 Mn | -427.25 Mn | 7.20 Mn | 56.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 56.23 Mn |
| Mar 31, 2026 | 61.37 Mn |
| Dec 31, 2025 | 78.44 Mn |
| Sep 30, 2025 | 83.22 Mn |
| Jun 30, 2025 | 163.54 Mn |
| Mar 31, 2025 | 15.94 Mn |
| Dec 31, 2024 | 23.70 Mn |
| Sep 30, 2024 | 16.06 Mn |
| Jun 30, 2024 | 34.76 Mn |
| Mar 31, 2024 | 17.90 Mn |
| Dec 31, 2023 | 14.81 Mn |
| Sep 30, 2023 | 5.05 Mn |
| Jun 30, 2023 | 6.56 Mn |
| Mar 31, 2023 | 5.02 Mn |
| Dec 31, 2022 | 14.56 Mn |
| Sep 30, 2022 | 11.07 Mn |
| Jun 30, 2022 | 12.02 Mn |
| Mar 31, 2022 | 26.22 Mn |
| Dec 31, 2021 | 38.83 Mn |
| Sep 30, 2021 | 44.76 Mn |
API Access
Abeona Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ABEO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ABEO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ABEO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();